Experimental Drug Reduces Melanoma Tumors

Wednesday, 22 May 2013 01:01 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink

Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer.
 
Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock Exchange on Wednesday. Its Nasdaq-listed shares were up 10 percent.
 
Reolysin was administered intravenously along with chemotherapy drugs carboplatin and paclitaxel to patients who either failed to respond to prior therapies or were not considered for standard first-line cancer treatment.
 
"These preliminary results are very encouraging and support progressing to subsequent studies," said Chief Executive Brad Thompson.
 
Oncolytics said it will not proceed with the second stage of the trial at this time as it try the drug in combination with other emerging treatments.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Late Flu Wave Hits Northeast

Saturday, 19 Apr 2014 09:46 AM

A second, milder wave of flu is hitting the Northeast. Months ago, the flu season seemed to be winding down. But healt . . .

Singer Debbie Gibson Reveals Battle With Lyme Disease

Friday, 18 Apr 2014 17:07 PM

Singer Debbie Gibson says that he was diagnosed last year with Lyme disease, a tick-borne illness that can cause joint p . . .

Food Poisoning Strikes Food Safety Meeting

Friday, 18 Apr 2014 16:43 PM

Maryland health officials are investigating a suspected outbreak of food poisoning among government and business leaders . . .

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved